# Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development (PAR-28-043)

**Plain-English Eligibility Score:** 73/100

| Field | Value |
|---|---|
| Opportunity number | PAR-28-043 |
| Title | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development |
| Agency | National Institutes of Health |
| Status | forecasted |
| Posted / open date | 2026-07-07 |
| Close date | Estimated 2027-06-16 |
| Award ceiling | n/a |
| Award floor | n/a |
| Estimated total funding | n/a |
| Funding category | Health |
| Eligible applicants | Public and State controlled institutions of higher education; Public housing authorities/Indian housing authorities; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Small businesses; Native American tribal governments (Federally recognized); City or township governments; Private institutions of higher education; For profit organizations other than small businesses; County governments; Native American tribal organizations (other than Federally recognized tribal governments); Independent school districts; Others (see text field entitled "Additional Information on Eligibility" for clarification); State governments; Special district governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Eligibility notes | Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions). |
| CFDA / Assistance listing | 93.853 |
| Summary | The NIH Blueprint for Neuroscience Research is interested in continuing to support the B lue P rint N eurotherapeutics Network for S mall M olecules (BPN-SM)- a program designed to help investigators advance promising small-molecule therapeutics toward clinical testing. The BPN-SM program supports drug discovery and development activities in investigators’ own laboratories while also providing access to NIH-supported subject matter experts and contract research organizations (CROs) with capabilities in medicinal chemistry, pharmacokinetics, toxicology, formulation development, GMP synthesis, and Phase I clinical testing. By integrating NIH resources with industry-standard expertise, BPN-SM a |
| Agency contact | BPNSMNINDS@mail.nih.gov |

## Why this score
- Small businesses are listed as eligible applicants.
- Nonprofits are listed as eligible applicants.
- Forecasted: you can prepare before the notice is posted.

Source: Grants.gov (U.S. Department of Health and Human Services) (https://www.grants.gov/search-results-detail/363095). Last refreshed: 2026-11-03T18:08:06.385Z.
Data from Grants.gov. Always read the full notice of funding opportunity before applying. Informational only; not legal or grant-writing advice.